-

Nexus Pharmaceuticals Launches Baclofen Injection Refill Kit

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announces the launch of their Baclofen Injection Refill Kit. Nexus’ kit will be the only one on the market that offers a vial presentation.

“We are proud to be supplying healthcare systems with not only a life-changing drug, such as Baclofen, but also with a convenience kit to deliver the medication in a safe, accommodating, and timely fashion,” says Omair Ahmed, Chief Operating Officer at Nexus. “This kit will ease the lives of those living with long-term severe spasticity conditions.”

Baclofen Injection Refill Kits are available now. Order through your Wholesaler today or from Customer Service at (888) 806-4606.

Unit of Sale NDC: 14789-0161-01

  • Cencora – 10298638
  • Cardinal – 5981196
  • McKesson – 3025269
  • Morris & Dickson – 596312

About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.

Contacts

Grace Conroy
gconroy@nexuspharma.net
847-527-7490

Nexus Pharmaceuticals, LLC


Release Versions

Contacts

Grace Conroy
gconroy@nexuspharma.net
847-527-7490

More News From Nexus Pharmaceuticals, LLC

Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Wins Patent Litigation For Injectable Cyclophosphamide, Paving Way For Generic...

Nexus Pharmaceuticals Launches Methylene Blue Injection

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood’s ability to carry oxygen. “The launch represents a vital addition to Nexus’ growing portfolio of life-saving and difficult-to-manufacture medications,” said Usman Ahmed, CEO of Nexus Pharmaceuticals. “Methylene Blue is a critical drug in emergency care, and...

Nexus Pharmaceuticals Launches Fluorescein 2 mL

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market. Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer Service at (888...
Back to Newsroom